Cargando…
Edoxaban Exposure‐Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep‐Vein Thrombosis or Pulmonary Embolism
Edoxaban exposure‐response relationships from the phase III study evaluating edoxaban for prevention and treatment of venous thromboembolism (VTE) in patients with acute deep vein thrombosis (DVT) and/or pulmonary embolism (PE) were assessed by parametric time‐to‐event analysis. Statistical signific...
Autores principales: | Nyberg, J, Karlsson, KE, Jönsson, S, Yin, OQP, Miller, R, Karlsson, MO, Simonsson, USH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846783/ https://www.ncbi.nlm.nih.gov/pubmed/27299709 http://dx.doi.org/10.1002/psp4.12077 |
Ejemplares similares
-
Thrombosis in an Internal Jugular Vein and an Upper Limb Deep Vein Treated with Edoxaban
por: Toratani, Mizuho, et al.
Publicado: (2017) -
Superior mesenteric vein thrombosis treated with edoxaban
por: Hashizume, Yutaka, et al.
Publicado: (2017) -
Extensive deep vein thrombosis treatment using fondaparinux and edoxaban: a case report
por: Shimizu, Kazuhiro, et al.
Publicado: (2016) -
The Prevalence of Concomitant Deep Vein Thrombosis, Symptomatic or Asymptomatic, Proximal or Distal, in Patients With Symptomatic Pulmonary Embolism
por: Hirmerova, Jana, et al.
Publicado: (2018) -
The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
por: Shimizu, Kazuhiro, et al.
Publicado: (2018)